Biocon Market Cap

Biocon has a market cap or net worth of 523.98 billion as of December 5, 2025. Its market cap has increased by 34.57% in one year.

Market Cap

523.98B

Enterprise Value

690.81B

Revenue

164.76B

Ranking

n/a

PE Ratio

100.54

Stock Price

392.65

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 523.98B, an increase of 1,053.80%. That is a compound annual growth rate of 11.94%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	523.98B	19.83%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	551.59B	58.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,331.52B
Divi's Laboratories	1,718.51B
Cipla	1,228.46B
Apollo Hospitals Enterprise	1,033.74B
Zydus Lifesciences	937.26B
Mankind Pharma	910.34B
Aurobindo Pharma	707.18B
Alkem Laboratories	678.59B

Market Cap Rankings